Medicare Coverage of Smoking Cessation Medications Worse Than Medicaid, Private Insurance, Study Says
Patients with Medicare were 5.08 times more likely than patients with private insurance, and 2.81 times more likely than patients with Medicaid, to face a financial barrier to obtaining varenicline and combination nicotine replacement therapy.
Source: ajmc.com
